Update: Positron Corporation Announces CEO Agenda for Media and Analyst Conference

Media and Investors are Invited to the MarketSite, New York City, Wednesday, May 5, 2010, 1:00pm EDT


NEW YORK, May 4, 2010 (GLOBE NEWSWIRE) -- Positron Corporation (OTCBB:POSC), a molecular imaging solutions company focused on Nuclear Cardiology, today announced that its CEO Patrick Rooney and senior executives will present at the NASDAQ MarketSite in Times Square, New York City, NY.

Topics to include: updates on new business initiatives, strategic alliances and global distribution partnerships.

Senior executives will also discuss the company's leadership driving Cardiac PET's (positron emission tomography) expanding dominance as the preferred nuclear cardiology imaging modality over legacy technology SPECT (single-photon emission computerized tomography). Positron has the only dedicated PET system in the marketplace.

When: May 5, 2010, 1:00 pm EDT

Where: NASDAQ MarketSite, 4 Times Square, New York, NY  

RSVP required for building security: 917-680-6011, bradley.smith@muncmedia.com

Webcast:

CLICK HERE to schedule webcast in your calendar. Click "open" and the "Save and Close" when prompted.

CLICK HERE to watch the event May 5, 1:00pm

Positron Corporation executives will be available for interviews.  Please call 917-680-6011 to schedule.

About Positron:  Positron is a molecular imaging company focused on Nuclear Cardiology.  Positron utilizes its proprietary product line to provide unique solutions to the Nuclear Medicine community ranging from imaging systems to radiopharmaceutical distribution.  Positron products include: the Attrius™, a PET imaging device; the Pulse®, a SPECT imaging device; the Nuclear Pharm-Assist®, an automated radiopharmaceutical distribution device; and the Tech-Assist™, a radiopharmaceutical injection shield.  As a prominent player in the cardiac imaging industry, Positron maintains associations and relationships with multiple industry associations including the Academy of Molecular Imaging, American College of Cardiology American Society of Nuclear Cardiology and Society of Nuclear Medicine. Positron founded in 1983, is headquartered in Indianapolis, Indiana.  More information about Positron is available at www.positron.com.

Forward Looking Statements:  Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended.  These statements are based on many assumptions and estimates and are not guarantees of future performance and may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Positron Corporation to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements.  Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission.



            

Contact Data